We have designed a pipeline for performing Virtual Clinical Trials of optical imaging of skin lesions. This pipeline includes modules to simulate healthy skin and subcutaneous tissue, to create skin lesions and insert those in the skin models, and to simulate the acquisition of optical images resulting in simulated/virtual images of skin. The last module of the pipeline performs virtual reading of simulated images, which is based on the clinical task-based performance analysis. The physical properties of the skin and lesions used in our simulations were selected to represent clinically plausible conditions. Skin lesion images were simulated assuming the ambient white light, and a linear camera model. We have utilized the standards for optimal data representation based upon the XML schema, adopted from the VCT pipeline developed for breast imaging research.
INTRODUCTION
Skin cancer is one of the most common cancers in Western countries. More people are diagnosed with skin cancer each year in the U.S. than all other cancers combined 1 . One person dies of melanoma every hour in the U.S. 1 Worryingly, the incidence of cutaneous melanoma among young adults is rapidly increasing 2 .
In skin lesion diagnostics, traditional optical dermatoscopes are still the standard equipment used by dermatologists, which allows the inspection of skin lesions unobstructed by skin surface reflections. Dermatoscopes can be either contact or non-contact, based on the type of lesion that is to be examined; open wound lesions tend to require non-contact based dermatoscopes. Most traditional dermatoscopes are analogue devices, relying on the subjective examination of the medical examiner present. Some companies have introduced basic digital dermatoscopes 3 though these are mostly limited to attaching a digital camera to an otherwise analogue dermatoscope to enable the acquisition of digital images.
There are also present a few dermatoscope add-ons to the smartphone which provide patients the ability to snap their own pictures of lesions and have them sent / checked across the corresponding application on the smartphone 4 .
Digital dermatoscopes allow the dermatologist to have a second look at the lesion without the burden of having the patient present at all times, as well as to be able to monitor the evolution of a lesion over time. There are current efforts to develop a novel digital dermatoscope optimized for skin cancer imaging 5 . Apart from benefits of digital imaging, they provide multispectral lighting 6 as well as possible embedded decision support which is something yet to be found in other dermatoscope models. Multispectral lighting provides the ability to view lesions and their effects at various depths. Different wavelengths of light penetrate to different depths into the skin, thus able to give spectral characteristics and concentrations of various chromophores in the skin 7 .
Bringing such novel devices into the market would require multiple clinical trials with a large number of patients imaged repeatedly to compare the performance of different systems or system settings. Optimization and validation of such a dermatology imaging system is therefore very challenging. The associated cost, duration, and the burden to patient volunteers participating in the trials, represent a significant impediment to the introduction of novel imaging technologies into clinical practice.
In this paper we propose an efficient alternative for the optimization and validation, in the form of Virtual Clinical Trials (VCTs) of dermatology imaging.. VCTs allow quantitative and objective assessment of the imaging system performance, and the performance of novel imaging methods. This computer simulation pipeline proposed for VCTs of dermatology imaging (hereafter VCT-Derma) is described in Section 2.1.
One section of the VCT-Derma pipeline requires a software model of the skin. This model represents a skin volume of interest, containing simulated normal skin anatomical structures, as well as (optionally) simulated abnormalities (malignant or non-malignant lesions, and/or other clinically relevant findings). There are models of the skin that are available in literature, some of which are the Breault's Advanced Systems Analysis Program (ASAP) model 8 , which takes several parameters (the anisotropy factor, the scattering coefficient, the absorption coefficient, and the fractional obscuration per unit area) as input and provides us with a simulation skin model on which ray tracing could be run, and a simplified model of the skin available in the breast imaging VCTs proposed by Bakic et al. 9 The skin model used in our VCT-Derma pipeline is described in Section 2.2.1 VCT-Derma also requires an optical simulation of light propagation within the skin model. A BioSpec model by Krishnaswamy, A et.al 10 describes light propagation in terms of ray optics, and is simulated as a random walk process.
Funamizu et.al 11 shows how certain ray tracing tools could also be used to obtain a rough 3 layer model of the skin, each layer characterized by four optical properties: refractive index, absorption coefficient, scattering coefficient and scattering anisotropy, and thickness. Some of the basics of the light propagation model used in our VCT-Derma pipeline is described in Section 2.2.3
While raytracing software like ASAP 12 and LightTools 13 do help us produce images from skin models, they all have a serious disadvantage in that the simulation time is extremely long due to the algorithms being CPU-based. There are also certain GPU based Monte Carlo Simulations(MCS) which achieve speed increases of up to 3 orders of magnitude over a CPU-based MCS 11 , but since the VCT-Derma implementation in Blender 14 is mainly CPU-based, these GPU implementations were not delved into.
In order to be able to run virtual trials of a dermatascope, the images that are obtained should resemble dermatoscopic images upto a sufficient level of accuracy (luminance/colour errors lower than 10%). Through the above mentioned methods, we may obtain models that may have the properties of the skin lesion but not the appearance, the latter of which is what we aim to achieve with our model.
A generally observed problem in the skin imaging simulations (including ASAP model) is the fact that the model and software are proprietary, which limits cross-validation of results and impedes development of the field by, and considering the novel nature of the research, any changes that are unique to our dermatoscope or our application. Therefore our composite skin tissue model is an extension of the basic skin model included in the breast anatomy simulation 15, 16 . While sufficient for requirements of breast imaging VCTs, this basic model lacked detail layered structure of human skin, needed for the efficient simulation of dermatological imaging. A look at a possible model with multiple layers and skin structures is what is detailed in this paper. The model in question has been developed in a tool akin to a game engine (Blender), which has not been looked into before for similar applications. Results of some preliminary te pipeline deve
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Figure 1: Flow optical images
The use of a success with grade display models 17 The reader model will be either a CAD or AI model whose purpose is to be able to simulate the image analysis and classification, performed by a clinical dermatologist.
The final block is the Performance Analysis block and it contains parameters required to run task-based criteria tests and compute the corresponding figures of merit, such as the area under the receiver operating characteristic (ROC) curve, or the percent correct score.
All these blocks/modules are controlled by the VCT Manager block. Thanks to the XML schema data representation, the VCT-Manager Block can access / call the headers from each of the modules. So depending on the task to be performed, a certain set of modules are called to perform the task.
The Virtual Image Reader and Performance Analysis modules have been designed based upon the Medical Virtual Imaging Chain (MeVIC) 17 also used as a part of the breast imaging VCTs pipeline.
For this paper, we have performed preliminary proof-of-concept tests of the proposed VCT pipeline to assess the effect of varying skin, and lesion, thickness, and position on the appearance of simulated images. Preliminary tests did not include virtual readings and performance analysis.
Virtual Patient Accrual
Skin Model
Human skin tissue can roughly be divided into three layers, as illustrated in Figure 2: (1) epidermis, the outermost layer, (2) dermis, the middle one, and (3) hypodermis, the subcutaneous tissue. The thickness of the skin layers has been documented in literature (and can also be seen in the Figure 2) . In order to create a reliable skin model for the VCT-Derma, it is vital to understand the interaction of radiation, such as visible light, with human skin. The optical properties of the layers of the skin are elaborated in great detail in literature 20 , but are summarized below.
Human skin contains light-absorbing and scattering molecules -otherwise known as chromophores -including eumelanin, pheomelanin, hemoglobin, bilirubin, beta carotene, and water, the properties of which change with the wavelength of light incident upon them. They are responsible for complex elastic and inelastic 20 scattering events that can be wavelength dependent. Volume components such as blood vessels, glands etc. also affect the optical properties of the skin, and are in fact quite important in determining the severity of a skin lesion, or even in classifying the type of cancer 18 .
Models such as the ASAP model utilizes the Henyey-Greenstein approximation 21 to volumetric light-scattering simulations. In this software, four parameters are necessary to create a volumetric-scattering model: the anisotropy factor, the scattering coefficient, the absorption coefficient, and the fractional obscuration per unit area. The ASAP model allows researchers to simulate light interactions in the stratum corneum, epidermis, dermis, and hypodermis of human skin -with provisions for hair, blood vessel, dermal papillae (refers to the finger like projections that create the uneven boundaries between consecutive skin layers), and fluorescence characterization -as well as single and multilayer tissue models based on bulk-scattering approximations 20 .
A simple model of the skin was also developed for the breast imaging VCT model 16 . This model varies from the current VCT-Derma in the sense that the model in the latter is the skin and it's interaction with visible light, while the former involves a breast model and it's interaction with x-rays. The basic skin layer in the breast imaging VCT model was represented by a layer of a certain thickness to prove a barrier for the x-rays. This is not the case in the VCT-Derma, where the skin and its multiple layers and structures are of vital importance. The skin model is expected to have multiple influencing characteristics (light absorbing chromophores, blood vessels etc.) which determine the severity of the cancer / lesion.
On comparing these two models in question, we see that the ASAP model has the advantage in that it provides us the options to model the layers of the skin, and their properties; therefore, the work left to be done is on selecting optimal values of these optical properties (the anisotropy factor, the scattering coefficient, the absorption coefficient, and the fractional obscuration per unit area). With these values, the ASAP software should be able to generate a skin phantom. The breast imaging VCT model on the other hand, requires more extensive work to be done with regards to the layers and their respective chromophore content, apart from also obtaining their optical properties from research.
The pitfalls on raytracing methods with CPU/GPU have already been mentioned in the introduction which brings about the need for a much faster and more visually acceptable skin model that could be passed to a dermatologist. Realistic rendering of human skin and light has always been a very important aspect in the computer graphics industry. There exist a number of computer graphics based software (Unity 22 , Unreal 23 , Maya 24 etc.) that are available which can realistically render human skin. The software that has been decided on is called Blender 14 which will be explained further in section 2.2.3.
In this paper we have created a basic two layer skin model; the layers being the epidermis and the dermis. The layer specifications can be seen in section 2.2.3. Since this paper is a proof of concept and a preliminary implementation, this will be a good starting point. There is a possible third layer that could have also been included which is the hypodermis / subcutaneous tissue layer below the dermis, but this was deemed unnecessary because the depth at which it is located has little influence on the lesion or the dermatologist's diagnosis.
Since the VCT pipeline has the goal of being adapted for dermatology, it makes sense to assume the skin model to be one form of skin cancer prevalent today1. A lesion is therefore inserted into the model.
Lesion Model
In general, a skin lesion refers to an abnormal lump, bump, ulcer, sore or colored area on the skin 25 . They can be either benign or malignant. Our work is c and evolution for the scope obtain a prelim the skin. Figure.6 shows the skin sections and corresponding simulated images, for the lesions of different size inserted into a skin model with 3mm thick dermis. Lastly, we varied the depth of lesion insertion (from just touching the epidermis to 1.75mm from the epidermis-dermis border. Figure.7 shows the skin sections and corresponding simulated images.
(a) (b) (c) (a) . Meglinky et.al 29 discussed the optical and physical properties for each of these layers, as well as the significant role in skin optics of rough boundaries between layers of different refractive index. The wavy layer interfaces produce a deeper and more homogeneous distribution of photons within the skin and tend to suppress the direct channeling of photons from the source to detector.
Another notable lack in the current model has to do with a blood network. Future work will include a reasonable network of blood capillaries to be able to better simulate the appearance of skin. Different vessel morphologies are associated with different melanocytic or non-melanocytic skin tumors; thus, the recognition of distinctive vascular structures may be helpful for diagnostic purposes 18 .
Future work with regards to the lesion will be to move from a regular spherical shape to one that better reflects the randomness of a malignant lesion, as mentioned earlier. Some of the main factors on which dermatologists classify / diagnose lesions have to do with the ABCD parameters 31 which account for the asymmetry, border, color and dermatoscopic structures present in the lesion. Hence future work could also include some of these factors taken into account
CONCLUSION
We propose a simulation pipeline for VCTs of skin lesion imaging, named VCT-Derma. The pipeline is based upon our previously developed VCTs of breast imaging. Simulated images from a proof-of-concept test show visually plausible appearance. In this paper we detail the first of the pipeline modules for Virtual Patient accrual, which includes the Skin, and Lesion Models. Integration of these models with the remaining pipeline modules, as well as the detailed simulation of skin tissue structure is ongoing.
